What is the catalog number for Recombinant Human IL29 (IFNL1)?

The catalog number for Recombinant Human IL29 (IFNL1) is Z100509.

What sizes are available for Recombinant Human IL29 (IFNL1)?

Recombinant Human IL29 (IFNL1) is available in the following size(s): 1 mg.

Is Recombinant Human IL29 (IFNL1) in stock?

Recombinant Human IL29 (IFNL1) is currently made to order / not held in immediate stock. Contact us for lead time.

Recombinant Human IL29 (IFNL1)

The IFN-lambda gene family is composed of three distinct genes: IFN-lambda1 (IL-29), IFN-lambda2 (IL-28A), and IFN-lambda3 (IL-28B). IFN-lambda proteins exhibit only weak homology to IL-10, but, like IL-10, they also use the IL-10R2 chain as a component of their receptor complex. The IFN-receptor complex consists of the unique ligand-binding chain IFN- R. The IFN-lambda-1 gene is found exclusively in primate genomes and is 81% identical to IFN-lambda-2/3. IFN-lambda-s, which are now collectively referred to as type III IFNs, exhibit several features in common with type I IFNs, such as antiviral, antiproliferative, and antitumor activities.

Product Specifications

CAS Number

9000-83-3

Gene Name

IFNL1

Gene Aliases

Interferon lambda-1, IFN-lambda-1, Cytokine Zcyto21, IL-29<br/>Recombinant Human Interleukin-29 (IFNL1)

Gene ID

282618

Accession Number

Q8IU54

Organism

Human

Source

E. coli

Concentration

<1.0 EU/μg of recombinant protein as determined by the LAL method.

Purity

>95% as determined by SDS-PAGE

Solubility

A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers.

Function

The ED(50) is determined in an anti-viral assay using human HepG2 cells infected with EMCV is typically 1-5 ng/mL.

Molecular Weight

20

Shipping Conditions

Ambient Temperature

Storage Conditions

The lyophilized protein is stable for at least one year from date of receipt at -70°C. Upon reconstitution, this cytokine can be stored in working aliquots at 2° - 8°C for one month, or at -20°C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles.